GlaxoSmithKline Intellectual Property Development Limited
发明人:
Danton BOUNDS,Jenny L. CRAIGEN,William E. FIELES,Fiona M. GERMASCHEWSKI,Gaelle HERLEDAN,Lydia LEE,Patrick A. MAYES,Lee MCCAHON,Katherine (NEE SULLY) NEVIN,Jennifer PATERSON,Manuel RODRIGUEZ-JUSTO,Laur
申请号：
US15771622
公开号：
US20180306791A1
申请日:
2016.10.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that binds BCMA. Also provided are kits for measuring BCMA expression in a sample.
